Health claims

EFSA rejects coffee’s DNA damage-reducing claim

EDITOR'S SPOTLIGHT: SCIENCE AND REGULATION

EFSA rejects coffee’s DNA damage-reducing claim

By Will Chu

European regulatory authorities have rejected statements that claim consuming an Arabica roast coffee blend could reduce DNA damage occurring in white blood cells.

©Motion Nutrition

NEWS IN BRIEF

Nootropic startup removes brain disease claim on ASA ruling

By Will Chu

Motion Nutrition has addressed an Advertising Standards Authority (ASA) ruling which deemed a description of its nootropic supplement as a claim to be able to protect against neurodegenerative diseases.

Follow us

Products

View more

Webinars